A novel approach to restore lung immunity during systemic immunosuppression

Area of Science:

• Immunology
• Pulmonology
• Gene Therapy

Background:

• Systemic immunosuppression leads to high rates of morbidity and mortality globally.
• Pulmonary infections are the primary cause of death in immunosuppressed individuals.
• Alveolar macrophage (AM) function is critically impaired by immunosuppression, compromising lung immunity.

Purpose of the Study:

• To investigate if AMs can restore alveolar immunity in immunosuppressed mice.
• To determine if gene transfer of gamma interferon into AMs enhances their function.
• To evaluate the efficacy of AMs in clearing opportunistic lung infections in immunodeficient models.

Main Methods:

• Intratracheal instillation of normal and gamma interferon (IFN-γ)-activated macrophages into severe combined immunodeficiency (SCID) mice.
• Assessment of macrophage distribution, phagocytic function, and clearance of Pneumocystis carinii.
• Evaluation of immune reconstitution in the lungs despite systemic immunosuppression.

Main Results:

• Airway delivery of macrophages led to widespread alveolar distribution and improved phagocytic capacity.
• Delivered AMs effectively cleared opportunistic infections like Pneumocystis carinii.
• IFN-γ-expressing AMs demonstrated enhanced functionality compared to normal AMs.

Conclusions:

• Reconstitution of lung immunity is achievable through airway delivery of AMs in immunosuppressed hosts.
• Gene-modified AMs offer a potential strategy to bolster lung defense mechanisms.
• This approach restores alveolar immunity, even under conditions of ongoing systemic immunosuppression.